Back to search

Article

Angiotensin-converting enzyme inhibitors (ACEI) or Angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

2020-09-25

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> To investigate the effects of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blockers (ARBs) administration to hypertension patients with the coronavirus disease 2019 (COVID-19) induced pneumonia.<bold>Methods: </bold>We recorded the recovery status of 67 inpatients with hypertension and COVID-19 induced pneumonia in the Raytheon Mountai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a44ad1e6-7672-5dbf-bb7d-140e0188d64c
DOI
10.21203/rs.3.rs-51043/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Angiotensin-converting enzyme inhibitors (ACEI) or Angiotensin receptor blockers (ARBs) may be safe for COVID-19 patientsDOI 10.21203/rs.3.rs-51043/v2
Select a neighboring publication to make it the new centre.